Enzyme Manufacturing Facility
Aiding next-gen genomics
A global genomics leader, Illumina provides comprehensive, next-generation sequencing solutions to the research, clinical, and applied markets. The company develops and commercializes next-generation sequencing and array platforms to fuel groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, and agriculture, among others.
Space-constrained in its existing leased building, Illumina turned to Flad to conduct a feasibility study to explore multiple options for new construction. This led to the selection of a site close to Illumina's existing space that could accommodate a generous program for the present, as well as room for future expansion. Specific goals for the resulting project included flexible, reconfigurable process suites based on a modular planning grid; a pleasing and energetic work environment that fosters interaction and communication among staff; and connectivity between the lab and office environments.
The new 130,000-square-foot, two-story GMP facility is organized around a main circulation corridor with manufacturing/lab areas and a service corridor to the west, and office areas to the east. The hub at the intersection of the north and south wings of the building includes a lunch room and conferencing center designed to promote collaboration and interaction among staff. The warehouse and central utility plant inhabit a separate 16,000-square-foot building linked to the main structure. Flad performed laboratory programming and full architectural services for interior shell fit-out in the new facility.
Project TypeScience & Technology